Monitoring of the 5-FU therapy: Safety and efficacy of treatment?
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue
Abstract
5-fluorouracil (5-FU) is one of the most common chemotherapeutics used in the therapy of cancers of the gastrointestinal tract, breast, skin or head and neck. The key enzyme of drug metabolism is encoded by DPYD dihydropyrimidine dehydrogenase (DPD), which is responsible for the catabolism of 80% of the administered 5-FU. Patients with DPD deficiency are exposed to a high risk of severe and sometimes lethal toxicity during treatment. Nonlinear pharmacokinetics and narrow therapeutic index significantly hinder the prediction of response of the body after administration of a standard dose. Therefore, the individual adjustment of the optimal dose enabling the best possible therapeutic effect with minimal side effects is very important. The commonly accepted method of adjusting 5-FU dose is based on the body surface area (BSA). Unfortunately, this does not allow us to determine the drug concentration ensuring the highest effectiveness of the treatment while maintaining its safety. Many publications point out the need of determining the activity of dihydropyrimidine dehydrogenase before the administration of 5-FU, which could result in obtaining the desired and optimal drug concentration in the blood, without exposing the patient to its excessive toxicity. Despite the great needs, such tests are not carried out routinely. Specification of procedures of DPD activity indication, determination of optimal 5-FU doses and monitoring of concentration of this chemotherapeutic during the treatment can become the basis for establishing some new therapeutic standards in the oncology, and in consequence, may significantly influence the quality and length of life of the patients.
Authors and Affiliations
Angelika Szczęśniak, Aleksandra Goryniak, Daria Śleboda, Barbara Dołęgowska
Keywords
Related Articles
- EP ID EP270218
- DOI 10.5604/01.3001.0011.5962
- Views 164
- Downloads 0
Chirurgiczne wycięcie rozległych kłykcin kończystych odbytu jest operacją nie powodującą ryzyka zwężenia odbytu
Wstęp: Kłykciny kończyste odbytu były już dobrze znaną chorobą w starożytności, ale w ostatnich latach obserwuje się szybki wzrost liczby osób cierpiących na tę chorobę. Główną przyczyną tej choroby jest zakażenie wirus...
Applications of electromagnetic radiation in medicine
Recent decades have been devoted to the intense search for the response to questions related to the impact of radiation on the human body. Due to the growing fashion for a healthy lifestyle, increasing numbers of works a...
Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro
Aim: The aim of our study was to compare the cytotoxic effects of bendamustine (BENDA) and rituximab (RIT) used either alone or in combination and to evaluate the influence of the above mentioned drugs on apoptosis measu...
Analiza taksonów roślin nasiennych wykorzystywanych w badaniach płytek krwi
The CRISPR-Cas system – from bacterial immunity to genome engineering
Precise and efficient genome modifications present a great value in attempts to comprehend the roles of particular genes and other genetic elements in biological processes as well as in various pathologies. In recent yea...